Key points are not available for this paper at this time.
Statins decrease mortality and cardiovascular events in persons with early stages of CKD, have little or no effect in persons receiving dialysis, and have uncertain effects in kidney transplant recipients.
Palmer et al. (Tue,) studied this question.